RenovoRX
  • News
  • Careers
  • Investors
  • About
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • Clinical Trials
    • About TIGeR-PaC
    • TIGeR-PaC
      Candidate Criteria
    • TIGeR-PaC Participating
      Clinical Sites
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • Contact
  • About
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • Clinical Trials
    • About TIGeR-PaC
    • TIGeR-PaC
      Candidate Criteria
    • TIGeR-PaC Participating
      Clinical Sites
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact
Investors

Investors

  • Overview
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Overview
    • Press Releases
    • Clinical News
    • IR Calendar Events
    • Email Alerts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Presentations

  • Company Info

  • Overview
  • Management Team
  • Presentations
  • Contacts
  • FAQ
Mar 15, 2022

Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at ROTH Capital Partners 34th Annual Conference, March 2022

Mar 2, 2022

Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at Maxim Virtual Growth Conference, March 2022

Mar 1, 2022

Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at ROTH Capital Partners 34th Annual Conference, March 2022

Feb 15, 2022

“Delivering Therapy Where it Matters” Fireside Chat with CEO, Shaun Bagai Webinar, February 2022

Jan 15, 2022

Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at H.C. Wainwright Bioconnect Conference, January 2022

rss_feed RSS
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Email Alerts
  • Contacts
  • RSS News Feed

4546 El Camino Real, Suite B1
Los Altos, CA 94022

(650) 284-4433

(650) 397-4433

RenovoRX

Delivering Therapy Where it Matters

Quicklinks
  • About
  • Clinical Trials
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact

Delivering Therapy Where it Matters

4546 El Camino Real, Suite B1
Los Altos, CA 94022

(650) 284-4433

(650) 397-4433

Quicklinks
  • About
  • Clinical Trials
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact

© Copyright 2018-2023 RenovoRx®. All rights reserved. Site by Sheriar Designs.

Privacy Statement | Terms of Use

Menu